Pleural mesothelioma, predominantly linked to asbestos exposure, remains a formidable clinical challenge characterized by late diagnosis, poor therapeutic responsiveness, and dismal survival rates. Traditional bulk tissue analyses have failed to adequately capture the intricate cellular heterogeneity and spatial organization within tumor microenvironments. Addressing these limitations, the investigators employed multiplexed single-cell technologies to dissect individual cellular phenotypes, while complementary spatial profiling modalities illuminated their precise architectural context within tumor specimens.

The study’s comprehensive immune profiling revealed a striking enrichment of B cells residing within TLS—ectopic lymphoid aggregates that mimic secondary lymphoid organs—embedded in the mesothelioma microenvironment. Unlike diffuse immune infiltrates, these structures exhibited highly organized T-cell and B-cell zones, follicular dendritic cell networks, and adaptive immune gene expression signatures resembling germinal centers. This structural sophistication suggests active local immune responses possibly modulating tumor progression.

Delving deeper into the transcriptional profiles, the research highlighted that the presence and abundance of these TLS, as well as the density of intratumoral B cells, strongly correlated with favorable clinical outcomes. Patients exhibiting robust TLS formations had markedly improved overall survival compared to those lacking such immunological niches, positioning these features as powerful prognostic biomarkers. This revelation shifts the paradigm regarding the role of humoral immunity within solid tumor contexts historically dominated by T-cell-centric perspectives.

The methodology leveraged in this research represents a milestone in cancer immunology. By integrating single-cell RNA sequencing with spatial transcriptomics—two technologies that have individually transformed molecular oncology—the team achieved an unprecedented resolution in mapping immune cell subsets and their microanatomical relationships. This multiplexed approach untangles cellular crosstalk within the tumor microenvironment, identifying not only cell types but their functional states and interactions driving clinical heterogeneity.

Notably, the data suggest that B cells within TLS may contribute to anti-tumor immunity via several mechanisms, including antigen presentation, antibody production, and modulation of T-cell responses. The precise immunological pathways remain to be fully elucidated, but the correlation with patient survival underscores the therapeutic potential of augmenting B cell-mediated immunity or TLS formation in pleural mesothelioma.

The clinical implications are profound. Current immunotherapy regimens, largely focused on checkpoint inhibitors targeting T cells, have yielded limited benefits in mesothelioma. The recognition of B cells and TLS as key players invites the exploration of novel therapeutic strategies aimed at stimulating humoral immune components or enhancing TLS development to boost endogenous anti-cancer responses.

The study also reflects the evolution of tumor immunology from descriptive histopathology to dynamic, high-dimensional mapping. It exemplifies how multiplex analysis can dissect complex immune landscapes that determine tumor progression or regression. Such insights pave the way for improved biomarker-driven clinical trials and personalized immunotherapeutic interventions tailored to the immune microenvironmental context.

Moreover, the presence of TLS has been reported variably across cancers like lung, breast, and colorectal tumors, but their role in mesothelioma was previously underexplored. By definitively associating TLS with better prognosis in pleural mesothelioma, this research fills a critical knowledge gap and highlights the need for systematic spatial immune profiling in diverse cancer types.

Technically, achieving multiplexed single-cell and spatial profiling requires meticulous tissue processing, advanced computational pipelines, and integrative bioinformatic analyses. The authors’ ability to implement these sophisticated techniques on limited mesothelioma biopsy samples demonstrates feasibility for clinical research settings, potentially enabling real-time immune monitoring.

As the field moves forward, coupling these spatial immune insights with genomic and epigenomic datasets could further refine molecular subclasses of mesothelioma, revealing vulnerabilities exploitable by combination therapies. The emphasis on B cells and tertiary lymphoid structures opens new avenues not only for prognostication but also for the rational design of immunomodulatory agents.

This paradigm shift stresses the importance of viewing the tumor microenvironment as an immune ecosystem where cellular neighborhoods, rather than isolated cell types, dictate therapeutic outcomes. Enhancing TLS formation or function might synergize with existing immunotherapies, turning “cold” tumors into “hot” ones, more amenable to immune intervention.

Future directions highlighted by the investigators include validating these findings in larger, multi-institutional cohorts and investigating the mechanistic underpinnings of B cell-TLS interplay in mesothelioma biology. Additionally, exploring how environmental factors like asbestos exposure influence TLS development may deepen understanding of tumor immunity’s origins.

In conclusion, the innovative multiplexed single-cell and spatial profiling study provides compelling evidence that B cells and tertiary lymphoid structures constitute vital prognostic indicators in pleural mesothelioma. This work marks a decisive advancement in unraveling the complex cancer-immune dialogue and establishes a foundation upon which next-generation immunotherapies may be developed to improve survival outcomes in this challenging malignancy.

Subject of Research: Immune profiling in pleural mesothelioma focusing on B cells and tertiary lymphoid structures as prognostic indicators using multiplexed single-cell and spatial profiling technologies.

Article Title: Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma.

Article References:
Rigutto, A., Núñez, N.G., Kienzler, J.C. et al. Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma. Br J Cancer (2026). https://doi.org/10.1038/s41416-026-03421-1

Image Credits: AI Generated

DOI: 27 April 2026

Cervical squamous cell carcinoma remains a critical global health challenge, predominantly caused by persistent infection with high-risk HPV strains. Despite advancements in screening and vaccination, understanding the early molecular events leading to malignant transformation has been limited. In this context, the Xinjiang cohort’s scRNA-seq profiling has delineated keratinocyte subpopulations directly associated with HPV presence, marking a significant leap forward in characterizing the tumor microenvironment’s (TME) complexity.

Through rigorous sequencing of both tumor and adjacent normal cervical tissues from early-stage CESC patients, the investigators identified keratinocytes with high co-expression of PI3 and S100A7 as being disproportionately enriched within the tumor compartment. These PI3+S100A7+ keratinocytes exhibited transcriptional signatures denoting activated oncogenic pathways, including NF-κB and TNF signaling cascades, which are crucial mediators of inflammation and tumor progression. The pronounced expression of cytokine-receptor interaction genes within this subset underlines their role in orchestrating local immunological dynamics.

Spatial transcriptomic analysis and immunohistochemical validation revealed that these keratinocytes are frequently localized in proximity to CD163+ tumor-associated macrophages (TAMs). This juxtaposition suggests a bidirectional crosstalk wherein keratinocytes and macrophages co-activate signaling networks that facilitate tumor growth, promote invasion, and potentially aid immune evasion. These interactions encompass key chemokines and cytokines such as CCL2, CXCL8, and IL-10, which modulate macrophage recruitment and polarization, thus reshaping the immune milieu within the TME.

Intriguingly, the prognostic implications of PI3+S100A7+ keratinocyte infiltration were substantiated using The Cancer Genome Atlas (TCGA) data, wherein elevated presence correlated with significantly worse patient survival outcomes. Patients exhibiting high concurrent infiltration of both these keratinocytes and CD163+ macrophages showed the most pronounced decrease in overall survival, underscoring the clinical relevance of this cellular interplay.

Further dissecting stromal components, the study identified four fibroblast subtypes within tumor versus adjacent tissues. Among these, cancer-associated fibroblasts (CAFs) manifesting an inflammatory phenotype (C1 subtype) were predominantly expanded in tumor regions. These CAFs activated pathways that may synergize with keratinocyte-macrophage signaling to foster a pro-tumorigenic extracellular matrix and facilitate malignant progression, whereas undifferentiated fibroblasts (C3 subtype) mainly resided in non-cancerous tissues, indicating distinct stromal remodeling patterns.

Professor Ruozheng Wang, principal investigator, emphasized the dual significance of PI3 and S100A7, noting their marked overexpression in HPV-driven cervical cancer samples relative to normal controls. Immunohistochemistry not only confirmed co-localization but delineated a clearly defined keratinocyte subpopulation contributing uniquely to tumor biology. This finding advances the understanding of HPV-induced transcriptional reprogramming at the cellular level.

Moreover, the study underlines macrophages as key effectors modifying the TME through their enriched presence and potent crosstalk with keratinocytes mediated by pro-inflammatory and immunosuppressive factors, such as tumor necrosis factor (TNF) and interleukin-10 (IL-10). This milieu likely facilitates viral persistence and promotes early oncogenic transformation, posing challenges for immune clearance.

The intricate dialogue between HPV-infected keratinocytes and immune cells as revealed by this work highlights the dynamic remodeling of the tumor microenvironment, where viral oncogenesis intertwines with immune modulation and stromal reprogramming. This multifaceted interplay orchestrates an environment conducive to malignant initiation and progression, providing novel avenues for therapeutic intervention.

Importantly, this research advocates for targeting the identified signaling pathways and cell populations therapeutically. Inhibitors or immunomodulatory agents specifically designed to disrupt keratinocyte-macrophage communication or CAF activation could provide transformative strategies to halt or reverse early cervical cancer progression, marking a paradigm shift toward precision oncology.

This study not only enriches the molecular understanding of HPV-driven cervical carcinogenesis but also underscores the potential of single-cell technologies to unravel cellular heterogeneity and complex intercellular interactions within tumors. By pinpointing critical players like PI3+S100A7+ keratinocytes, it sets the groundwork for future diagnostics and targeted therapies demanding early-stage intervention.

In conclusion, the identification of this keratinocyte subtype reshaping the tumor microenvironment through crosstalk with immune and stromal elements opens new research frontiers. It paves the way for precise molecular targeting in early cervical squamous cell carcinoma and exemplifies how integrating high-resolution single-cell methodologies can revolutionize cancer biology and patient care.

Subject of Research: Cells
Article Title: Single-cell analysis identifies PI3+S100A7+ keratinocytes in early cervical squamous cell carcinoma with HPV infection
News Publication Date: 20-Oct-2025
Web References: Chinese Medical Journal article
References: DOI: 10.1097/CM9.0000000000003795
Image Credits: Professor Ruozheng Wang from The Affiliated Tumor Hospital of Xinjiang Medical University
Keywords: Cervical cancer, Oncology, Tumor microenvironments, Keratinocytes, Single cell sequencing, Immunology, Molecular biology, Gene expression, Biomarkers